We are live on !
Find out more
Persistent Asset Partners Portfolio holdings
AUM
$335M
Turnover
79.96%
1-Year Est. Return
275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
(+25%)
Cap. Flow
-$37.3M
Cap. Flow % of AUM
Cap. Flow %
-11.13%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$16M |
| 2 |
STMicroelectronics
STM
|
+$13.6M |
| 3 |
Amphenol
APH
|
+$10.9M |
| 4 |
Seagate
STX
|
+$7.07M |
| 5 |
Ford
F
|
+$6.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$18.4M |
| 2 |
Lumentum
LITE
|
+$14.5M |
| 3 |
AXT Inc
AXTI
|
+$13.3M |
| 4 |
Tower Semiconductor
TSEM
|
+$11.9M |
| 5 |
Micron Technology
MU
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.35% |
| 2 | Healthcare | 29.66% |
| 3 | Financials | 6.33% |
| 4 | Miscellaneous | 6.14% |
| 5 | Consumer Discretionary | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
26
Micron Technology
MU
$1.03T
| $2.37M | 0.71% |
2,053
-14,497
| -88% | -$10.9M |
2025 Q4
2 quarters
|
|
27
CALL
Viking Therapeutics
VKTX
$3.35B
| $2.27M | 0.68% |
3,105
+1,433
| +86% | +$46.3K |
2025 Q3
3 quarters
|
|
28
Onto Innovation
ONTO
$10.9B
| $2.25M | 0.67% |
+5,947
| New | +$1.68M |
2026 Q2
0 quarters
|
|
29
Kodiak Sciences
KOD
$5.51B
| $2.18M | 0.65% |
56,052
+4,716
| +9% | +$183K |
2026 Q1
1 quarter
|
|
30
TripAdvisor
TRIP
$1.11B
| $2.17M | 0.65% |
158,456
+58,456
| +58% | +$661K |
2025 Q4
2 quarters
|
|
31
Pinduoduo
PDD
$112B
| $2.15M | 0.64% |
28,145
+13,413
| +91% | +$1.24M |
2025 Q3
3 quarters
|
|
32
Advanced Energy
AEIS
$9.9B
| $2.14M | 0.64% |
+5,747
| New | +$2.01M |
2026 Q2
0 quarters
|
|
33
NexGen Energy
NXE
$5.72B
| $2.13M | 0.63% |
226,741
-11,212
| -5% | -$127K |
2024 Q4
6 quarters
|
|
34
Eldorado Gold
EGO
$9.12B
| $2.09M | 0.62% |
67,090
+14,844
| +28% | +$483K |
2024 Q4
6 quarters
|
|
35
Entegris
ENTG
$22.6B
| $2.08M | 0.62% |
+11,568
| New | +$1.67M |
2026 Q2
0 quarters
|
|
36
Immunocore
IMCR
$1.65B
| $2.07M | 0.62% |
65,214
+16,252
| +33% | +$481K |
2025 Q1
5 quarters
|
|
37
CALL
Abivax
ABVX
$8.16B
| $2.07M | 0.62% |
890
+637
| +252% | +$72.1K |
2026 Q1
1 quarter
|
|
38
Precigen
PGEN
$2.36B
| $2.03M | 0.61% |
355,767
+341,789
| +2,445% | +$1.48M |
2026 Q1
1 quarter
|
|
39
Bitdeer Technologies
BTDR
$2.19B
| $1.99M | 0.59% |
125,248
+32,383
| +35% | +$465K |
2026 Q1
1 quarter
|
|
40
Nebius Group N.V.
NBIS
$46.6B
| $1.98M | 0.59% |
7,153
-11,013
| -61% | -$2.18M |
2025 Q3
3 quarters
|
|
41
4D Molecular Therapeutics
FDMT
$697M
| $1.94M | 0.58% |
+145,585
| New | +$1.42M |
2026 Q2
0 quarters
|
|
42
Amcor
AMCR
$20.9B
| $1.86M | 0.55% |
42,900
+13,361
| +45% | +$530K |
2026 Q1
1 quarter
|
|
43
Navan Inc
NAVN
$6.93B
| $1.83M | 0.54% |
+79,842
| New | +$1.46M |
2026 Q2
0 quarters
|
|
44
Arcus Biosciences
RCUS
$2.43B
| $1.76M | 0.52% |
57,048
-3,155
| -5% | -$78K |
2026 Q1
1 quarter
|
|
45
MKS Inc
MKSI
$14.6B
| $1.59M | 0.47% |
3,577
+3,057
| +588% | +$957K |
2026 Q1
1 quarter
|
|
46
CALL
Corcept Therapeutics
CORT
$12.6B
| $1.55M | 0.46% |
524
+123
| +31% | +$7.43K |
2026 Q1
1 quarter
|
|
47
Expand Energy Corp
EXE
$21.5B
| $1.51M | 0.45% |
17,175
+4,098
| +31% | +$389K |
2025 Q4
2 quarters
|
|
|
TGB
48
Trekor Metals
TGB
$2.91B
| $1.47M | 0.44% |
214,277
-15,328
| -7% | -$110K |
2025 Q1
5 quarters
|
|
49
TORM
TRMD
$4.04B
| $1.46M | 0.44% |
+56,215
| New | +$1.7M |
2026 Q2
0 quarters
|
|
50
Johnson & Johnson
JNJ
$621B
| $1.42M | 0.42% |
5,605
-7,988
| -59% | -$1.86M |
2025 Q4
2 quarters
|
|
Similar funds
PI
Persistent Asset Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.
- Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
- Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
- Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
- Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
- Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
- Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
- Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.